ArticleClinical rheumatology2017

Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis.

Ufuk İlgen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.